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Supercharged proteins (SCPs) can deliver functional
macromolecules into the cytoplasm of mammalian
cells more potently than unstructured cationic
peptides. Thus far, neither the structural features of
SCPs that determine their delivery effectiveness nor
their intracellular fate postendocytosis, has been
studied. Using a large set of supercharged GFP
(scGFP) variants, we found that the level of cellular
uptake is sigmoidally related to net charge and that
scGFPs enter cells through multiple pathways, in-
cluding clathrin-dependent endocytosis and macro-
pinocytosis. SCPs activate Rho and ERK1/2 and
also alter the endocytosis of transferrin and EGF.
Finally, we discovered that the intracellular traf-
ficking of endosomes containing scGFPs is altered
in a manner that correlates with protein delivery
potency. Collectively, our findings establish basic
structure-activity relationships of SCPs and impli-
cate the modulation of endosomal trafficking as
a determinant of macromolecule delivery efficiency.
INTRODUCTION
The vast majority of nucleic acids and proteins encoded by
the human genome are intracellular. Molecular strategies to
perturb the function of most biological targets for research or
therapeutic purposes, therefore, require agents that can enter
cells. Although membrane-permeable small molecules have
dominated therapeutics over the past several decades, the use
of macromolecules to address biomedical targets has more
recently become a focus of intense research (Leader et al.,
2008), resulting in a number of macromolecular human drugs
(Overington et al., 2006). Macromolecules can offer significant
advantages over traditional small molecule-based therapeutics.
Macromolecules possess sizes and folding energies that are
ideal for catalyzing chemical reactions, potently and selectively
binding to extended target surface areas, and encoding gene
products. These key features, juxtaposed with the inability of
virtually all macromolecules to spontaneously enter cells, create
an urgent need to develop effective and general methods for the
delivery of functional proteins and nucleic acids into mammalian
cells (Schaffert and Wagner, 2008; Gu et al., 2011).Chemistry & Biology 19,Although a host of protein delivery methods has been devel-
oped over the past decade—most notably those based on
cationic cell-penetrating peptides (CPPs) (Wadia and Dowdy,
2003; Heitz et al., 2009), but also including antibodies (Song
et al., 2005), receptor ligands (Rizk et al., 2009), nanoparticles
(Hasadsri et al., 2009), and virus-like particles (Voelkel et al.,
2010)—these approaches have not achieved widespread use,
and modestly successful protein delivery has historically
required high doses of purified protein. We recently developed
a platform for macromolecule delivery in vitro and in vivo based
on supercharged proteins (SCPs) (Cronican et al., 2010, 2011;
McNaughton et al., 2009). SCPs possess extremely high-posi-
tive theoretical net charge at their surfaces, and candidate
SCPs can be generated computationally from native, non-SCPs
(Lawrence et al., 2007). Proteins can be mutated into SCPs
without necessarily abolishing the protein’s native structural or
functional properties (Lawrence et al., 2007). Recently, we
identified a class of naturally occurring supercharged human
proteins with theoretical net charge:molecular weight ratios
similar to those of engineered SCPs (Cronican et al., 2011).
These naturally occurring human SCPs exhibit potent cellular
uptake and macromolecule delivery properties similar to engi-
neered SCPs. When compared to the most commonly used
CPPs and commercial nucleic acid delivery reagents, SCPs
can result in more effective protein and nucleic acid delivery
across a range of cell and tissue types in vitro and in vivo (Croni-
can et al., 2010, 2011; McNaughton et al., 2009).
The molecular mechanisms by which SCPs enter and are traf-
ficked in cells are largely unknown. Previous studies suggest that
cell entry of SCPs shares some mechanistic features with that of
other cationic delivery reagents (McNaughton et al., 2009), such
as binding to sulfated proteoglycans to mediate initial cellular
association, followed by endocytosis and some degree of endo-
somal escape to the cytosol. However, SCPs can be more effi-
cient at achieving both cell entry and functional macromolecule
delivery to the cytosol than CPPs (Cronican et al., 2010;
McNaughton et al., 2009). To our knowledge, it is not understood
whether the high-delivery potency of SCPs compared with CPPs
results solely from the higher theoretical net charges attained by
SCPs or from the globular, structured nature of SCPs compared
with much shorter and less-structured peptide tags. Observa-
tions that support the latter hypothesis include (1) increasing
the theoretical net charge of CPPs beyond approximately +15
typically does not increase, and eventually decreases, their cell
penetration potency (Mitchell et al., 2000); (2) substitution of
arginines on the surfaces of small proteins has been shown to831–843, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 831
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Schepartz, 2007) beyond those of similarly charged cationic
peptides; (3) the cell penetration capabilities of oligoarginine
peptides have been enhanced by the introduction of disulfide
bonds that presumably stabilize the three-dimensional structure
of the cationic peptide (Lee et al., 2011); (4) introducing spacer
sequences between cationic residues throughout an oligoargi-
nine peptide has also been shown to increase the effectiveness
of cellular uptake (Rothbard et al., 2002); and (5) the distribution
of cationic residues on the surface of proteins, and not merely
charge magnitude, has been shown to alter the effectiveness
of certain cell-penetrating proteins (Turcotte et al., 2009).
Consistent with these findings, we have observed that SCPs
exhibit more potent cell penetration and nucleic acid delivery
abilities than synthetic peptides of similar or even greater posi-
tive theoretical net charge (McNaughton et al., 2009).
In this work we investigate in detail the role of theoretical net
charge and charge distribution on the cellular uptake and
delivery properties of SCPs using supercharged GFP (scGFP)
as a model. We examined the extent to which SCPs and CPPs
alter endocytic processes using a wide range of biochemical
assays and high-throughput confocal microscopy. We find that
cellular uptake and delivery potencies are strongly charge
dependent and that SCPs outperform unstructured peptides of
similar charge. We further find that delivery potency correlates
with the activation of specific cellular signaling markers, altered
endocytosis, and subcellular trafficking. These findings provide
mechanistic insights into the unusual ability of SCPs to enter
cells and deliver macromolecules, and inform the future develop-
ment and application of these agents.
RESULTS
Effect of Charge Magnitude on Cellular Uptake
Previously, we observed that the CPPs Tat, Arg10, and penetratin
delivered protein into cells with up to 100-fold lower potencies
than that of +36 GFP (Cronican et al., 2010) and that protein
and nucleic acid delivery efficiencies mediated by three scGFP
variants (+15, +25, and +36 GFPs) correlated with their theoret-
ical net charge (McNaughton et al., 2009). These observations
prompted us to characterize in detail (1) the relationship between
net theoretical charge and cellular uptake potency, and (2) the
effect of charge distribution, either across the surface of a protein
or within an unstructured peptide tag, on cellular uptake and
delivery potency.
To elucidate these relationships, we generated a collection of
28 scGFP variants with awide range of theoretical net charges as
well as different patterns of charge distribution (see Figure S1
available online). Genes encoding the variants were con-
structed by combining DNA fragments derived from the coding
sequences of previously developed GFPs: stGFP (starting
GFP, a nonsupercharged variant), +15 GFP, +25 GFP, +36
GFP, and +48 GFP (Lawrence et al., 2007). Each resulting scGFP
variant was expressed and purified from E. coli cells. The absor-
bance and fluorescence emission spectra of all 28 scGFPs were
very similar (Figure S2), enabling us to use fluorescence to
directly compare the cellular uptake of these proteins.
To determine the relationship of charge-to-cell uptake, each
scGFP variant was incubated with HeLa cells for 4 hr across832 Chemistry & Biology 19, 831–843, July 27, 2012 ª2012 Elsevier La range of concentrations. Following incubation, cells were
washed using conditions previously shown to remove excess
noninternalized protein (Cronican et al., 2010, 2011; McNaugh-
ton et al., 2009), trypsinized, and assayed for protein uptake by
flow cytometry. For comparison, Tat-stGFP and a GFP engi-
neered by Raines and coworkers to contain an arginine patch
(Fuchs and Raines, 2007) were also incubated with HeLa cells
and processed in an identical manner. The degree of cellular
uptake was measured as the median cellular fluorescence of
the population of cells. The relationship of theoretical net
charge-to-cellular uptake was found to be strongly sigmoidal
and consistent across doses ranging from 20 nM to 2 mM
(Figure S3). Low-potency uptake, comparable to that of Tat
peptide, was observed among proteins with a net theoretical
charge less than+20. In contrast a high-potency regime exhib-
iting 100-fold higher cellular uptake potency was observed for
highly charged proteins (Figure 1A). For GFP the inflection point
between the low- and high-potency regimes occurs at a theoret-
ical net charge of approximately +22 (Figure 1A, green points),
well above the net charge of CPPs. As this net charge versus
cellular uptake relationship predicts, Tat-stGFP (+1 theoretical
net charge) exhibited potency comparable to that of other
modestly charged, low-potency charged GFP variants, including
the Arg-grafted GFP (Fuchs and Raines, 2007) (Figure 1A). The
striking change in cell penetration effectiveness from low- to
high-potency variants suggests that these variants may enter
cells through the involvement of different cellular interactions
or through distinct uptake pathways.
Effect of Charge Distribution on Cellular Uptake
To examine the effect of SCP charge distribution on cell penetra-
tion, we generated a series of scGFPs that alter charge distribu-
tion without varying theoretical net charge, which was main-
tained at approximately +25 and +36. The variants within
this series were constructed from segments of +48 GFP
together with segments of +15 GFP and +25 GFP and, therefore,
contained a more uneven cationic charge distribution than
canonical +25 or +36 GFPs, with basic residues concentrated
into more limited regions of the protein surface. We observed
significantly different levels of cellular uptake potencies among
scGFPs with similar or identical theoretical net charges but
different charge distribution patterns (Figure 1B, red points).
These results confirm that the distribution of cationic groups on
the surface of a SCP, and not simply the theoretical net charge
of the protein, contributes to its cellular uptake properties.
To account for the possibility that interaction between densely
substituted cationic residues influences their protonation state
and the net charge of scGFPs, we performed cation exchange
and found that all proteins eluted in a manner consistent with
their relative theoretical net charge rather than with their
observed level of cellular uptake (Supplemental Experimental
Procedures; Figure S4). Additionally, we tested whether the
voltage of the scGFPs was affected by the distribution of
charged residues and found that some of the uptake deficiencies
of weakly performing scGFPs can be accounted for using
a model that describes the electric field of a protein in solution
(Supplemental Experimental Procedures; Figure S5).
Taken together, these findings are consistent with a model in
which at least one cellular uptake potency-determining event,td All rights reserved
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Figure 1. Charge Dependence of Cellular Uptake and Protein Delivery of scGFPs
(A) and (B) HeLa cells were treated with 200 nM of each purified scGFP for 4 hr, washed to remove surface-bound protein, and analyzed by flow cytometry. Plots
show fold median GFP fluorescence intensity relative to untreated control cells. Blue points represent scGFPs generated by shuffling stGFP, +15 GFP, +25 GFP,
and +36 GFP sequences. Red points represent scGFPs generated by shuffling stGFP, +15 GFP, +25 GFP, +36 GFP, and +48 GFP sequences to create proteins
with less even charge density. Green points represent starting +15, +25, +36, and +48 GFPs. The gray point is Tat-stGFP (Cronican et al., 2010), and the black
point is an arginine-grafted GFP (Fuchs and Raines, 2007).
(C) HeLa cells were treated with the indicated scGFP-mCherry for 4 hr, washed, and analyzed as in part (A). The plot showsmedian mCherry fluorescence of cells
relative to untreated cells.
(D) BSR.LNL.tdTomato Cre reporter cells were treated with scGFP-Cre fusions for 4 hr, washed, incubated an additional 48 hr, and assayed by flow cytometry.
(E) BSR.LNL.tdTomato reporter cells were treated and analyzed exactly as in (D) except that 100 mMchloroquine was added during the 4 hr protein incubation and
for an additional 12 hr after washing.
Error bars represent the SD of five (A–C) or three (D and E) experiments.
See also Figures S1, S2, S3, S4, S5, S11, and S12.
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et al., 2007), is dependent on the arrangement of cationic groups
on the surface of a SCP, and not simply on its net charge.
Charge Dependence of scGFP-Mediated Protein
Delivery
The cell penetration properties of macromolecule delivery
agents can depend strongly on the associated cargo (Cronican
et al., 2010). To determine whether the observed charge-uptake
relationship for scGFPs is sustained for scGFP-mediated
delivery of fused proteins, a subset of scGFPs was fused
to either mCherry or to Cre recombinase (Shaner et al.,
2004; Guo et al., 1997). GFPs with theoretical net charges
of +9, +15, +24, +25 (three variants designated +25, +25A,
and +25B), +35, +36, +37, and +48 were chosen as fusion part-
ners to cover a range of theoretical net charges and to includeChemistry & Biology 19,some variants with altered charge distributions that performed
below the level predicted by their theoretical net charge alone.
For comparison the CPPs Tat, Arg10, and penetratin were also
prepared as fusions with mCherry and Cre recombinase.
HeLa cells were incubated with mCherry fusions for 4 hr at
50 nM to 2 mM, washed, and analyzed by flow cytometry
using mCherry fluorescence as a measure of protein delivery.
The mCherry fusions retained the same general trend of
charge-dependent cellular uptake observed for scGFPs alone,
with low-potency delivery transitioning to high-potency delivery
(up to 50-fold more potent) for variants with >+15 theoretical
net charge (Figure 1C). We also observed lower cell penetra-
tion potency of the same high-charge variants that under-
performed in the cellular uptake study described above
(+25A, +25B, +35, +37, and +48 GFPs) (Figure 1C). Fusions
with CPPs performed as previously observed, with low overall831–843, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 833
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mCherry fusion, except for penetratin-mCherry, which resulted
in moderate levels of delivery at the highest concentrations
tested (1–2 mM).
Next, we used scGFP-Cre recombinase fusions to assay
the functional delivery of protein enzymes to the cytosol.
BSR.LNL.tdTomato cells (Cronican et al., 2010) were used to
report Cre-dependent recombination. Because scGFP-Cre
fusions have little or no recombinase activity until the scGFP
moiety is cleaved from the recombinasemoiety, we first digested
the purified proteins with the endosomal protease cathepsin B to
cleave the linker between scGFP and Cre and assayed the re-
sulting proteins in vitro as previously described by Cronican
et al. (2010). All cathepsin B-digested scGFP-Cre fusions ex-
hibited recombinase activities comparable to that of wild-type
Cre (Figure S6). In addition to being cleaved from scGFP, deliv-
ered Cre recombinase must also tetramerize, escape endo-
somes, translocate to the nucleus, and recombine the reporter
gene cassette to trigger tdTomato reporter gene expression.
Cells were incubated with each of the scGFP-Cre fusions across
a range of concentrations for 4 hr, washed to remove noninter-
nalized proteins as before, then incubated further in protein-
free media for 48 hr.
The percentage of recombinant cells resulting from each
treatment was revealed by flow cytometry. The Tat, Arg10, and
penetratin Cre fusions exhibited functional recombinase
delivery efficiencies in the low-potency regime, consistent with
previously reported results by Cronican et al. (2010, 2011).
Functional Cre delivery by scGFPs, in contrast to mCherry
delivery, was strictly charge-dependent, with higher-charged
scGFPs producing more recombinant cells and like-charged
variants clustering together (Figure 1D). Interestingly, variants
that were observed to be internalized with significantly lower
efficiency than +36 GFP, such as +37 GFP and +48 GFP,
when fused to Cre resulted in comparable or even greater re-
combinant cells than +36 GFP, respectively. The differences
between the cellular uptake potencies of these scGFPs (Fig-
ure 1C) and their strictly charge-dependent ability to deliver
functional Cre (Figure 1D) suggest that protein-intrinsic factors
downstream of internalization, such as cleavage of the fusion
or endosomal escape efficiency, are potency limiting in the
latter case.
To test these possibilities, Cre delivery was repeated in the
presence of chloroquine, a small molecule that enhances endo-
somal escape and increases functional delivery potency of SCPs
(Cronican et al., 2010). Importantly, the profile of charge- and
dose-dependent Cre recombination (Figure 1D) is significantly
shifted toward greater functional delivery in the presence of
100 mM chloroquine (Figure 1E) and closely reflects the pattern
of total fusion protein uptake (Figure 1C). To probe potential
differences in cleavage efficiency of Cre fused to different
SCPs, we subjected +15 GFP-Cre and +36 GFP-Cre to in vitro
and cell-based cleavage assays. Both proteins were found to
be equally cleavable (Figures S7A and 7B), suggesting that
proteolytic cleavage efficiency is not a determinant of the differ-
ently observed functional delivery abilities. We also assayed the
effect of blocking cleavage by coincubation of BSR reporter cells
with +36 GFP-Cre and a broad cathepsin inhibitor, Z-Phe-Gly-
NHO-Bz (Demuth et al., 1996). At low doses (0.1–0.5 mM), there834 Chemistry & Biology 19, 831–843, July 27, 2012 ª2012 Elsevier Lis a clear depression of delivery (Figure S8), presumably due to a
failure to liberate Cre from +36 GFP. At high doses (2–100 mM),
the efficiency ofCre delivery is dramatically improved (Figure S8),
possibly due to continued inhibition of endosomal proteases that
would otherwise degrade Cre.
Taken together, these results suggest that functional protein
delivery by scGFPs is charge-dependent and protease-depen-
dent and that this dependence is at least partially the result of
postinternalization processes. Processes that are likely to influ-
ence the intracellular survival and functional delivery of a protein,
such as endosomal trafficking, maturation, or escape, may
therefore be affected by the presence of highly cationic mole-
cules within endosomes, a hypothesis explored in the experi-
ments below.
Comparing Delivery Potencies of scGFPs and Similarly
Charged Cationic Peptides
The aforementioned studies implicate theoretical net charge as
a strong determinant of cell penetration and protein delivery
potency. Next, we sought to determine the effect of protein
structure on cellular uptake and protein delivery potency by
measuring the delivery efficiency of proteins fused to Arg- and
Lys-rich peptides with Lys/Arg content comparable to that of
scGFPs. Because genes encoding simple fusions of mCherry
or Cre to polycationic Arg or Lys peptides longer than ten amino
acids did not express efficiently in E. coli, we used an enzyme-
mediated protein ligation strategy to generate these proteins.
The synthetic peptides (KKR)3R, (KKR)6KR, and (KKR)9KRR
were efficiently conjugated to mCherry and Cre using a highly
active mutant sortase enzyme recently evolved in our laboratory
(Supplemental Experimental Procedures) (Chen et al., 2011). The
resulting poly-Lys/Arg-fused mCherry and Cre proteins were
incubated with reporter cell lines as described above. For
comparison, cells were also treated with mCherry and Cre fused
to +9, +15, +25, or +36 GFP, which collectively span the range of
theoretical net charges covered by the poly-Lys/Arg-fused
proteins. Cellular uptake and protein delivery potencies were
quantitated by flow cytometry as before.
For mCherry delivery, scGFP fusions consistently outper-
formed fusions with similarly charged poly-Lys/Arg-conjugated
mCherry (Figure 2A). This difference was especially pronounced
at lower concentrations. Although at higher concentrations
fusions with +20 and +30 peptides approached the performance
levels of fusions with +25 GFP, in most cases and at most
concentrations, scGFPs resulted in more mCherry delivery
than both similarly charged and more highly charged cationic
peptides (Figure 2B). These results indicate that scGFPs result
in distinctly more potent cellular uptake and mCherry delivery
than unstructured cationic peptides, even when the scGFP and
the cationic peptides possess a similar theoretical net charge.
The results for Cre recombinase delivery were generally
consistent with the mCherry delivery results: scGFP-Cre fusions
typically outperformed cationic peptide-Cre fusions, especially
at lower doses, with the exception of the lower potency +9
and +15 GFPs (Figure 2C). Interestingly, the +20 and +30 poly-
Lys/Arg peptides exhibited decreased Cre delivery potency
compared with +10 poly-Lys/Arg, which is approximately as
effective as Arg10-Cre (Figure 1D), despite the fact that all Cre
conjugates and fusions were comparably active in vitro followingtd All rights reserved
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Figure 2. scGFPs Deliver mCherry and Cre Recombinase More Effectively than Similarly Charged Cationic Peptides
Cells were treated and analyzed as described in Figure 1C.
(A) Median mCherry fluorescence of cells treated with scGFP-mCherry fusions or cationic peptide-mCherry conjugates at the indicated doses for 4 hr is shown.
(B) mCherry delivery efficiency as a function of protein net charge is presented.
(C) Percent recombinant BSR.LNL.tdTomato reporter cells expressing tdTomato following treatment with scGFP-Cre fusions or cationic peptide-Cre conjugates
are shown. Cells were treated and analyzed as described in Figure 1D.
Error bars represent the SD of three experiments.
See also Figures S1, S2, S3, S4, S5, S6, S7, S8, S11, and S12.
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Supercharged Protein Endocytosis and Traffickingcathepsin B treatment (Figure S7) (Cronican et al., 2010). A
possible explanation for the lower potency of the +20 and +30
poly-Lys/Arg peptides is their potential cytotoxicity, as has
been previously reported for certain cationic peptides and other
synthetic cationic polymers (Mitchell et al., 2000; Godbey et al.,
1999). This toxicity may not havemanifested on the shorter time-
scale of the mCherry internalization assays, whereas the Cre
assay is necessarily a multiday experiment.
Collectively, these results reveal a cellular uptake and protein
delivery-potency advantage from displaying positive charge on
a structured protein surface, as is this case with scGFPs, over
simply appending the same number of cationic residues in
a simple, presumably unstructured peptide tag. This difference
may be explained if the higher density of Arg and Lys side chains
in a short peptide prevents the complete protonation of every
residue by decreasing their pKa values to reduce unfavorable
charge-charge repulsion, decreasing the actual cationic net
charges attainable by synthetic peptides compared with SCPs.Chemistry & Biology 19,Alternatively, spreading cationic residues over a much larger
surface area may engage cell surface receptors or other proteins
involved in endocytosis and/or escape from endosomes more
effectively than concentrating cationic charge in a small peptide
tail. We tested the former possibility using the same cation
exchange-based approach that we used to assess the actual
charge magnitudes of scGFPs. Poly-Lys/Arg peptides eluted
from the cation exchange resin in a manner consistent with their
theoretical net charge (Figure S4). These results support a model
in which the potency differences between cationic peptides and
SCPs arise from differences in their ability to interact with cellular
components rather than from differences in their actual versus
theoretical net charge.
Mechanisms of scGFP Internalization
We previously reported that scGFP uptake is an energy-depen-
dent process that requires actin polymerization and the pres-
ence of cell surface-sulfated proteoglycans (McNaughton831–843, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 835
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Figure 3. Endocytic Pathway Probes, Alteration of Transferrin and EGF Uptake, and the Activation of Rho-GTP and ERK1/2 Phosphorylation
(A) Cells were pretreated for 1 hr with the indicated inhibitor prior to 1 hr treatment with 500 nM +36 GFP in the continued presence of inhibitor, washed, and
analyzed by flow cytometry. A mutant cell line, CHO pgsA, which lacks heparin sulfate proteoglycans, and treatment at 4C instead of 37C, were included as
a control (gray bars).
(B) and (C) HeLa cells cotreated with the indicated cationic protein or peptide for 4 hr and Texas red-labeled transferrin (B), or Alexa 594-labeled EGF (C), were
washed and analyzed by flow cytometry. Transferrin and EGF uptake were normalized to cells treated with (B) Texas red-labeled transferrin or (C) Alexa
594-labeled EGF alone.
(D–F) CHO cells (light bars) or CHO pgsA cells (dark bars) were treated with 1 mM of the indicated scGFP or cationic peptide for 5 min prior to washing and
harvesting of cell lysate. EGF treatment at 50 ng/ml was included as a control for signaling activation (‘‘EGF’’). (D) Rho-GTP quantitation by GLISA is illustrated. (E)
Rac-GTP quantitation by GLISA is shown. (F) The extent of ERK1/2 phosphorylation determined by immunoblot with anti-phospho ERK1/2 antibody and
quantitated by densitometry is presented.
Error bars represent the SD of three (A and C) or five (D–F) experiments.
See also Figures S1, S2, S9, S10, S11, and S12.
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Supercharged Protein Endocytosis and Traffickinget al., 2009). Given these findings, one possibility is that scGFP
may be taken up via macropinocytosis, similar to some CPPs
(Wadia et al., 2004; Nakase et al., 2007). In light of the observed
cellular uptake andmacromolecule delivery differences between
scGFPs and cationic CPPs, however, we hypothesized that
significant mechanistic differences in their cellular internalization
may also exist. We therefore probed the uptake of scGFP in
greater detail.
We used a collection of known endocytic inhibitors to probe
the role of different endocytic pathways in the uptake of scGFP.
HeLa cells were pretreated with each inhibitor for 1 hr prior to
incubation with 500 nM +36 GFP and inhibitor for an additional836 Chemistry & Biology 19, 831–843, July 27, 2012 ª2012 Elsevier Lhour (Figures 3A and S9). Cells were washed as described
above, and scGFP uptake was measured by flow cytometry.
Amiloride prevents the activation of macropinocytosis (Dangoria
et al., 1996), which is implicated in the uptake of cationic
CPPs, and inhibits Tat peptide delivery nearly completely at
5 mM (Wadia et al., 2004). In contrast, 5 mM amiloride reduced
uptake of scGFP by only 48%. Likewise, cytochalasin D, an
inhibitor of actin polymerization, blocked uptake of scGFP by
45% at 10 mM but has been reported to block Tat peptide
uptake by >90% (Wadia et al., 2004). These findings suggest
that, in contrast to most cationic CPPs, scGFP uptake is not
entirely dependent on macropinocytosis and actin-dependenttd All rights reserved
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Supercharged Protein Endocytosis and Traffickingprocesses. Interestingly, 5 mg/ml chlorpromazine, which pre-
vents the formation of clathrin-coated pits, and 50 mMdynasore,
which prevents the scission of clathrin-coated vesicles (Wang
et al., 1993; Macia et al., 2006), inhibited uptake of +36 GFP by
78% and 62%, respectively. Finally, nystatin and filipin, two
inhibitors of caveolin-dependent uptake that is involved in
the internalization of some viral delivery agents and nonviral
protein-based agents (Rothberg et al., 1990, 1992), resulted in
no observable impact on scGFP uptake at 50 nM of either inhib-
itor. These inhibitor studies collectively implicate a clathrin-
dependent endocytosis as a major mechanism for the uptake
of scGFP and suggest that macropinocytosis plays a lesser role.
To test whether scGFPs modulate clathrin-dependent uptake,
we incubated HeLa cells with fluorophore-labeled transferrin,
a known clathrin-dependent cargo, and Tat-mCherry, penetra-
tin-mCherry, (KKR)9KRR-mCherry, +15 GFP, or +36 GFP at
concentrations from 0.1 to 2 mM (Figure 3B). Coincubation
with +36 GFP resulted in a marked dose-dependent increase
in intracellular transferrin. None of the other proteins tested
had an appreciable effect on transferrin uptake. Titration of
transferrin (20–200 mg/ml) in the presence of 200 nM +36 GFP
had little effect on +36 GFP uptake, indicating that +36 GFP
does not use the same receptor as transferrin but instead stim-
ulates transferrin accumulation independently. We also tested
the +35 and +37 GFPs, two proteins that are taken up by cells
less efficiently than +36 GFP (Figures 1B and 1C), to see if their
lower potency could be explained by a differential effect on the
endocytic system but found no appreciable difference in intra-
cellular transferrin levels compared with +36 GFP (Figure S10A).
The stimulation of transferrin accumulation by +36 GFP may
implicate clathrin in the uptake of scGFP and suggests that
high-potency scGFPs potently alter endocytic processes that
rely on this pathway. These results also represent a distinction
between high-potency scGFPs and other proteins and peptides
tested.
Given the partial inhibition of +36 GFP uptake by the macropi-
nocytosis inhibitor amiloride, we tested the effect of epidermal
growth factor (EGF), a known inducer of macropinocytosis,
on +36 GFP uptake. Across a range of concentrations (0.1–
1 mg/ml), EGF had no significant impact on +36 GFP uptake (Fig-
ure S10B). However, when the internalization of labeled EGFwas
studied as function of the concentration of +36 GFP, +15 GFP,
Tat-mCherry, penetratin-mCherry, and (KKR)9KRR-mCherry
(0.1–2 mM each), EGF uptake was inhibited by +15 GFP, +36
GFP, and (KKR)9KRR-mCherry by up to 40% (Figure 3C).
This observation indicates that high-potency cell-penetrant
proteins such as +36 GFP may compete with EGF for receptors,
strongly induce ligand-independent internalization of EGF
receptors (EGFRs) (a known mechanism of EGFR regulation)
(West et al., 1989; Goh et al., 2010), or alter EGFR activation,
internalization, or degradation through another mechanism.
Finally, we examined whether scGFPs damage the cellular
membrane, thereby inducing endocytosis via membrane repair
pathways (Duchardt et al., 2007). Even at a high dose
(10 mM), +36 GFP does not induce appreciable membrane per-
meabilization (Figure S11).
Collectively, these mechanistic studies indicate that high-
potency scGFPs enter cells through uptake pathways that
include clathrin-dependent endocytosis, which may be alteredChemistry & Biology 19,by scGFPs, and macropinocytosis. Furthermore, scGFPs cause
significant changes to the transport of both recycling and degra-
dative endocytic cargoes. Such changes correlate with the
potency of protein delivery.
Rho Activation by scGFPs and Poly-Lys/Arg Peptides
The aforementioned observations suggest that scGFPs enter
cells through specific endocytic routes. Next, we characterized
the effects of scGFPs on key protein components in endocytosis
pathways. Charged peptides including Tat and Arg10 have been
shown to induce the activation of Rac GTPase (Nakase et al.,
2007), an early step required for the induction of macropinocyto-
sis. Rho and Rac are GTPases involved in cytoskeletal reorgani-
zation and endosomal trafficking (Lua and Low, 2005; Qualmann
andMellor, 2003). Rac is located near the plasmamembrane and
initiates actin polymerization at the start of macropinosome
formation (West et al., 2000). Rho is downstream of multiple
endocytic pathways, including caveolin-dependent uptake,
and clathrin-independent phagocytosis of particulate matter
(Ellis and Mellor, 2000). Rac, on the other hand, is associated
with fluid-phase endocytosis (West et al., 2000).
We assayed the activation of the GTP-bound form of Rho and
Rac GTPases by scGFPs and poly-Lys/Arg peptides using
a colorimetric plate-based ‘‘GLISA’’ (Cytoskeleton). The initial
binding events of scGFP and cationic peptides depend on asso-
ciation with sulfated proteoglycans (McNaughton et al., 2009),
and the binding and crosslinking of proteoglycans are known
to activate endocytosis (Wittrup et al., 2009; Dehio et al.,
1998). We therefore used CHO cells as well as mutant CHO
pgsA cells defective for xylosyltransferase (Esko et al., 1985),
which is responsible for sulfation of proteoglycans, as a control.
Cells were incubated for 5 min with proteins, harvested, and
lysed. The resulting cell lysates were applied to GLISA plates.
Upon treatment with high-potency scGFPs and poly-Lys/Arg
peptides, Rho was activated roughly 2-fold compared with
untreated controls (Figure 3D). Low-charge variants resulted in
significantly lower activation levels, consistent with the observed
sigmoidal charge-uptake relationship for scGFP and scGFP-
mCherry fusions (Figures 1A and 1C). Treatment of the CHO
pgsA cells resulted in low Rho activation across all treatments,
indicating that Rho activation is dependent on sulfated proteo-
glycans (Figure 3D, dark bars). Importantly, the activation of
Rho by scGFPs is consistent with our observation of a +36
GFP-dependent intracellular transferrin accumulation (Figure 3B)
because Rho plays an important role in clathrin organization,
cargo sorting, and endosome motility (Ellis and Mellor, 2000).
We also assayed the activation of GTP-bound Rac by GLISA
following treatment with scGFPs or poly-Lys/Arg peptides and
observed no activation by scGFPs and weak activation by
poly-Lys/Arg peptides (Figure 3E), consistent with observations
by others that Rac activation increases following treatment with
either Arg8 or Tat peptides (Nakase et al., 2007). Rho and Rac are
known to negatively regulate one another (Sander et al., 1999),
and significant Rho activation may depress Rac levels. Given
the role of Rho in the activation andmaturation of different endo-
cytic pathways (Ellis and Mellor, 2000; West et al., 2000), the
aforementioned results could provide a molecular explanation
for the scGFP-mediated alteration of transferrin and EGF endo-
cytosis (Figures 3B and 3C).831–843, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 837
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In many cell lines, endocytosis is required for full activation of
ERK1/2 following receptor ligation (Pierce et al., 2000; Robertson
et al., 2006; Ung et al., 2008). Therefore, changes in ERK1/2
phosphorylation can reflect activation of plasma membrane
signaling receptors by scGFPs or changes in the endocytic
transport of these receptors (Sorkin and von Zastrow, 2009).
We measured ERK1/2 phosphorylation by immunoblot anal-
ysis of cell lysates treated for 5 min with scGFP or poly-Lys/
Arg variants to quantitate phospho-ERK1/2 levels. Upon treat-
ment with highly charged scGFPs, but not similarly charged
poly-Lys/Arg peptides, cellular ERK1/2 was phosphorylated
by up to 8.4-fold over controls lacking treatment (Figure 3F).
More modestly charged (+9 or +15) scGFPs also induced
ERK1/2 phosphorylation, although to a lower extent (Figure 3F).
In all cases tested, ERK1/2 phosphorylation was also dependent
on the presence of sulfated proteoglycans, as evidenced
by the lack of ERK1/2 phosphorylation in the CHO pgsA cells
(Figure 3F, dark bars). This finding suggests that the activation
of receptor signaling, and possibly receptor internalization,
is an important factor in scGFP uptake. These results also
provide additional mechanistic distinctions of scGFP uptake
compared with the uptake of unstructured cationic peptides,
which have no significant effect on ERK1/2 phosphorylation
(Figure 3F).
Disruption of Endosomal Transport and Maturation
by scGFPs and Poly-Lys/Arg Peptides
The amount of material per endosome, the rate of intracellular
transport and maturation, and the ultimate destination of endo-
cytosed material are all parameters known to vary among endo-
cytic routes (Collinet et al., 2010). These distinctions can impact
the characteristics and effectiveness of protein delivery. A
comparison of scGFP uptake, scGFP-mCherry uptake, and
functional Cre delivery (Figures 1B–1D) suggests that charge-
dependent differences following internalization contribute to
the effectiveness of extraendosomal functional delivery of
protein cargoes. The high charge of cationic delivery reagents
could alter the ionic composition of the endosomal lumen.
Because the trafficking of endosomes is closely tied to the func-
tion of endosomal membrane ion channels and pumps (Huotari
and Helenius, 2011), significant alteration through such a mech-
anism could disrupt endosome transport and maturation. Endo-
cytosed cargoes targeted for degradation are transported to
perinuclear lysosomal compartments within approximately 2 hr
(Blanchette et al., 2009). The effective cytosolic delivery of endo-
cytosed material requires that it avoids degradation in the endo-
cytic pathway. A difference in the transport to lysosomes
between scGFPs and cationic peptides may explain the
observed variations in protein delivery data described above.
Wemonitored the transport of proteins to lysosomes following
internalization by incubation of HeLa cells with 500 nM of
a protein of interest for 1 hr. Following this incubation, cells
were washed extensively with PBS containing heparin, and incu-
bated a further 4 hr in protein-free media containing heparin to
prevent the uptake of any remaining extracellular protein and
inhibit the reinternalization of material from recycling endo-
somes. Dextran, a marker of fluid-phase endocytosis (Oliver
et al., 1984), was included as a control. Lysosomes were labeled838 Chemistry & Biology 19, 831–843, July 27, 2012 ª2012 Elsevier Lwith the LysoTracker reagent (Life Technologies), which effec-
tively labels acidified lysosomes.
We performed colocalization analysis of LysoTracker dye with
the scGFPs and cationic peptide-tagged mCherry proteins to
determine the extent of endosomal trafficking or maturation
disruption (Figure 4A). Dextran efficiently colocalized with lyso-
somes, resulting in a Pearson’s correlation coefficient (r) of
0.8. In contrast all delivered proteins displayed some level of
significantly slower transport, with none exhibiting r > 0.6. In
all cases, large numbers of protein-containing peripheral endo-
somes were observed, even 4 hr after removal of the protein
reagent from the media. Such a failure to localize to perinuclear
acidic vesicles suggests either a slowing of the maturation of
protein-containing endosomes or the sorting of scGFPs away
from the degradative pathway. The observation of peripheral
vesicles was not due to continued or recent internalization of
proteins because the cells were incubated in protein-free media
following washing and prior to imaging. Likewise, the apparent
peripheral distribution was not due to the degradation and disap-
pearance of otherwise perinuclear lysosomal material over time
because the total cellular fluorescence did not significantly
decrease over the course of the 4 hr incubation following treat-
ment (Figure S6).
The extent of lysosomal colocalization was significantly lower
for all scGFPs compared with any cationic peptide tested (Fig-
ure 4A). The scGFPs exhibited the least lysosomal colocalization
with a trend of decreased lysosomal localization with increased
charge (Figure 4A). Within the CPP set of Tat, Arg10, and penetra-
tin, the trend of colocalization strongly reflected functional
delivery properties, with Tat (the most potent delivery agent of
the cationic peptides in this study) exhibiting the lowest lyso-
somal colocalization. The colocalization data for the poly-Lys/
Arg peptides, in contrast, did not follow this trend. Although all
poly-Lys/Arg peptides showed significantly reduced lysosomal
colocalization compared to dextran, they were among the poor-
est performing domains in the Cre recombinase delivery assays
(Figure 2C). Importantly, the localization of scGFP signal strongly
correlates with that of fused proteins of interest, such as Cre,
even when the proteins are cleaved (Figure S13).
Collectively, these lysosomal localization results reveal that
the relative delivery abilities of scGFPs and CPPs correlate
with the extent of slowed endosomal maturation and that scGFP
exhibits a stronger effect on these processes than CPPs. That
such an effect correlates with the potency of functional delivery
suggests that the ultimate nonendosomal fate of delivered
proteins relies at least in part on how they are trafficked after
internalization.
Kinetics of scGFP and Cationic Peptide Uptake
and Trafficking
After observing the strong effect on endosome transport to lyso-
somes among the cationic delivery reagents tested, we charac-
terized the events of early endocytosis and tracked differences
between scGFPs and CPPs leading up to the observed late-
stage endosomal distribution using a recently reported high-
throughput confocal microscopy image analysis pipeline
(Collinet et al., 2010). This platform enables the measurement
of a wide range of endosomal parameters, including trafficking
kinetics, endosomenumber, size distribution, and cargo content.td All rights reserved
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Figure 4. Uptake and Trafficking Kinetics and Lysosomal Localization of scGFPs and Cationic Peptides
(A) HeLa cells were treated with 500 nM of scGFPs or peptide-mCherry fusions for 1 hr, washed, incubated an additional 4 hr, and imaged by confocal
microscopy. Lysosomes were labeled with LysoTracker Red or Green as appropriate (Life Technologies). The colocalization of proteins with lysosomes was
determined by calculation of the Pearson’s correlation coefficient of the red and green channels using ImageJ (left). A representative image of cells treated with
either FITC-Dextran (top right) or +36 GFP (bottom right) is shown.
(B) and (C) HeLa cells were incubated with the indicated scGFP or peptide-mCherry fusion at 500 nM for up to 2 hr and analyzed by confocal microscopy. (B) The
total amount of protein endocytosed over time. (C) Trafficking of protein through early endosomes (labeled with anti-EEA1 antibody; Rink et al., 2005) and
lysosomes (labeled with anti-LAMP1 antibody; BD PharMingen) is demonstrated. The number of GFP- or mCherry-containing vesicles showing EEA1 or LAMP1
colocalization was analyzed by high-throughput automated confocal microscopy (Collinet et al., 2010). In all plots, green points represent the total number of
vesicles containing scGFP or peptide-mCherry fusions, blue points are vesicles showing EEA1 colocalization, and red points are vesicles showing LAMP1
colocalization.
All error bars represent the SD of 3 experiments, except in (A), which shows the SD from 15 images.
See also Figures S1, S2, S11, S12, S13, S14, S16, and S17.
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Supercharged Protein Endocytosis and TraffickingAs representative proteins, we applied this strategy to the study
of +36 GFP (a high-potency SCP), +15 GFP (a modestly potent
SCP), Tat-mCherry, penetratin-mCherry, and +30 (KKR)9KRR-
mCherry (three cationic peptides of varying charge and size)
(for representative images see Figure S14).
HeLa cells were incubated with 0.1–2 mM of each protein for
30 min, washed, and fixed (Figure S15). Over a range of concen-
trations, the number of scGFP or CPP-containing vesicles
increased steadily (Figure 5A). Among the proteins tested, +36
GFP occupied the highest number of endosomes, even at low
concentration (0.1 mM), whereas other proteins did not occupy
such a high number of endosomes even at the highest dose
(2 mM). The +30 poly-Lys/Arg peptide exhibited a decrease in
the number of endosomes formed at high doses. Tat was only
detected in a small number of endosomes, consistent with its
modest cell uptake potency.Chemistry & Biology 19,Importantly, over a range of protein concentrations, the
amount of protein per endosome did not exhibit a significant
dose-dependent increase (Figure 5B). Endosomes with +36
GFP contained roughly 4- to 10-fold more protein per endosome
than endosomes with CPPs, whereas +15 GFP-containing
endosomes had roughly 2-fold more protein than CPPs. These
findings have important implications for interpreting the concen-
tration dependence of functional protein delivery. Although the
amount of protein per endosome is likely a factor contributing
to the overall effectiveness of protein functional delivery, as evi-
denced by the relative amounts of protein per endosome for +36
GFP and +15 GFP versus CPPs (Figure 5B), the number of endo-
somes containing endocytosed protein, rather than the amount
of protein per endosome, more closely correlates with dose-
dependent changes in functional delivery potency. Increasing
the dose of protein during treatments resulted in both more831–843, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 839
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Figure 5. Effects of scGFPs and Cationic Peptides on Endosome Formation, Endosomal Protein Content, and Endosome Surface Area
(A) and (B) HeLa cells were incubatedwith the indicated concentrations of scGFP or peptide-mCherry fusion for 1 hr, washed, and the number of GFP ormCherry-
containing endosomes was analyzed as in Figures 4B and 4C. (A) SCPs and cationic peptides are endocytosed with greatly different potencies. (B) High-potency
scGFPs fill endosomes with more protein than less-potent scGFPs and cationic peptides.
(C) and (D) HeLa cells were treated and analyzed exactly as in Figures 4 and 4C. (C) Amount of GFP or mCherry protein per endosome as a function of time is
illustrated. (D) Size of endosomes as a function of time, with the average size of early endosomes and lysosomes indicated by the dotted and solid lines,
respectively, is shown.
All error bars represent the SD of three experiments.
See also Figures S1, S2, S9, S11, S12, S14, S15, S16, and S17.
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Supercharged Protein Endocytosis and Traffickingprotein-containing endosomes and more potent functional
delivery (Figures 5A and 1D, respectively).
We next measured the uptake and trafficking of proteins over
time. Cells were incubated with 500 nM proteins for up to
2 hr. +36 GFP rapidly entered cells, filling a maximal number of
early endosomes (identified by the presence of EEA1; Rink
et al., 2005) within 10 min of treatment (Figure 4C). The other
proteins were much slower in their uptake, requiring as much
as 2 hr before reaching maximal early endosome occupancy.
Thereafter, +36 GFP quickly exited early endosomal compart-
ments. The rapid uptake and transport to early endosomes
of +36 GFP in comparison with the other proteins may reflect
the ability of this protein to be mainly internalized by clathrin-
mediated endocytosis, as described above (Figure 3A).
Over the course of 2 hr, a small fraction (<20%) of +36 GFP
eventually localized to late endosome compartments (identified
by the presence of LAMP1) (Figure 4C). Interestingly, the vast
majority of +36 GFP is unaccounted for in either of these major840 Chemistry & Biology 19, 831–843, July 27, 2012 ª2012 Elsevier Lendosomal populations, and the number and size of both
populations do not change significantly over time (Figures
S16A and S16B). The other proteins tested were slow to enter
both early endosomal compartments and late endosomal
compartments, whereas a major portion of the protein was
retained outside of either of these endosomal populations,
as with +36 GFP. The amount of protein degradation postendo-
cytosis, as measured by loss of fluorescence, was not appre-
ciable for any of the proteins within the 2 hr tested. The lack of
degradation over this period, and even over a longer 16 hr incu-
bation (Figure S12), suggests a role for dramatically reduced
lysosomal degradation in functional protein delivery. Indeed,
80% of the original +36 GFP signal remained within cells after
16 hr, indicating very little proteolysis of the endocytosed cargo.
In contrast the intracellular lifetime of other endosomal cargo is
comparatively short. For example transferrin can be recycled
out of the cell rapidly, with an intracellular half-life of 7 min
(Ghosh et al., 1994), EGF is almost completely degraded withintd All rights reserved
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Supercharged Protein Endocytosis and Trafficking2 hr (Carpenter and Cohen, 1976), and polystyrene beads are
transported to lysosomes within 2 hr (Blanchette et al., 2009).
The presence of intact protein within an endosomal reservoir
for several hours postinternalization may provide a much greater
opportunity for these proteins to escape endosomes, even
through a low-efficiency mechanism, than endosomal cargoes
that are rapidly degraded through canonical pathways.
Finally, wemeasured the amount of protein per endosome and
the sizeof endosomesover time. These twoparameters are indic-
ative of endosomal maturation and fusion andmay determine the
long-term fate of endocytosed proteins. Over 2 hr the average
amount of protein in each cell did not decrease for any protein
tested. However, unique among all proteins tested, the number
of +36 GFP-containing endosomes decreased sharply (Fig-
ure 4C). Consequently, the amount of +36 GFP per endosome
increaseddramatically over time (Figure5C). Thisproteinconcen-
tration effect was much less pronounced for the other proteins
tested, with +36 GFP reaching >5-fold more protein per endo-
some than any other agent tested, and achieving a 5-fold in-
crease in the amount of protein per endosomeover 2 hr. Theother
agents exhibited a much more modest increase in the amount
of protein per endosome during this time (Figure 5C). These
measurements suggest that +36GFP is not significantly inhibiting
homotypic fusion and cargo accumulation in endosomes. The
size of protein-containing endosomes did not change over time
appreciably for any protein tested (Figure 5D), and all endosomes
were smaller compared to both early and late endosomes.
These observations suggest a role for the long-term intracel-
lular survival of proteins within a unique peripheral endosomal
population during the process of functional protein delivery by
SCPs and cationic peptides. The endosomes occupied by +36
GFP are indeed acidified (Figure S17), yet they are not effectively
transported to late endosomes (Figure 4C) or lysosomes
(Figure 4A). Our observations for +36 GFP may reflect a unique
trafficking alteration that is shared at least in part by other poly-
cationic delivery reagents. The specific cause and consequence
of these changes are not obvious, but it is possible that a high
concentration of cationic moieties within an endosome disrupts
lumenal ion composition, preventing the maturation of protein-
containing endosomes and their subsequent fusion with degra-
dative compartments. If the intraendosomal survival of proteins
is extended as a result, then the delivery of functional extraendo-
somal proteins may strongly depend on such alterations to
endosomal trafficking.
DISCUSSION
In this study we found that the cellular uptake ability of scGFPs
exhibits a strong sigmoidal charge dependence. Such a relation-
ship suggests distinct interactions with cellular components
or uptake through different endocytic routes by high-charge,
high-potency scGFPs compared with CPPs or low-potency
scGFPs. Indeed, our subsequent mechanistic studies revealed
that high-potency scGFPs alone require clathrin and dynamin
for efficient uptake, and modify the transport of clathrin-depen-
dent endocytic cargoes. The potency of scGFPs correlates
with the level of activation of Rho and ERK1/2. Such activation
may involve the crosslinking of sulfated proteoglycans or other
receptors on the cell surface, a process known to induce macro-Chemistry & Biology 19,pinocytosis by CPPs (Imamura et al., 2011). If receptor crosslink-
ing is indeed the basis of endocytic activation by SCPs, then
perhaps the extended surface area provided by highly charged
variants explains their greater observed potency compared
with more modestly charged scGFPs or unstructured, short
cationic CPPs.
The endocytosis inhibitor and transferrin uptake studies
described above suggest that scGFP cellular uptake relies signif-
icantly on the induction of clathrin-dependent uptake. Although
internalization of scGFPs is still dependent on the presence of
anionic sulfated proteoglycans, the studies above suggest that
the major route of scGFP uptake is not macropinocytosis. These
results, combined with the mechanistic studies implicating
Rho and ERK1/2 activation, suggest that scGFP uptake likely
proceeds through multiple pathways and depends most heavily
on a proteoglycan-requiring, clathrin-dependent process.
We observed that both scGFPs and CPPs undergo an altered
process of trafficking following endocytosis. The delivery agents
tested here are not effectively transported to degradative lyso-
somal compartments. Moreover, the endocytosed proteins are
localized within abnormally small peripheral endosomes that
are negative for the early endosome marker EEA1. The magni-
tude of the changes to endosomal transport correlates with the
ability of each reagent to deliver cytosolic proteins. To our knowl-
edge, such changes in transport have not yet been reported for
nonviral delivery vehicles and have important implications for the
survival of delivered proteins within cells. If protein-containing
endosomes fail to mature and efficiently fuse with lysosomal
compartments, then delivered proteins may be provided with
an extended temporal window during which they can escape
into the cytoplasm. Such a phenomenon could contribute to
the effectiveness of all cationic delivery vehicles, especially
high-potency SCPs, which altered endosome trafficking more
than the other proteins and peptides studied here. To our knowl-
edge, the exact mechanism by which scGFPs and CPPs disrupt
endosomal transport is not yet understood and represents an
attractive subject of future studies. scGFPs also caused signifi-
cant changes to the transport of the endocytic cargoes trans-
ferrin and EGF, raising the possibility that SCPs have multiple
effects on specific molecular components of the endocytic
system that lead to changes in transferrin receptor and EGFR
recycling and degradation.
Together, our findings reveal insights into the mechanism of
cellular uptake and trafficking of SCPs and CPPs and more
generally highlight the importance of studying at the subcellular
level the interaction of delivery agents with their target cells.
Such studies improve our understanding of how macromolecule
delivery agents work, and identify means by which to optimize
their function. These studies also suggest ways in which
exposure to such delivery agents can alter cell physiology, an
important consideration as macromolecular medicines become
increasingly pervasive human therapeutics.
SIGNIFICANCE
Supercharged proteins (Cronican et al., 2010, 2011;
McNaughton et al., 2009) and other cell-penetrating agents
based on folded protein domains (Smith et al., 2008; Daniels
and Schepartz, 2007; Fuchs and Raines, 2007) represent an831–843, July 27, 2012 ª2012 Elsevier Ltd All rights reserved 841
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Supercharged Protein Endocytosis and Traffickingemerging class of macromolecule delivery agents that show
improved potency in delivery applications compared to
unstructured cationic peptides. In the current study we
discovered a highly sigmoidal, 100-fold charge-dependent
increase in cell uptake for highly charged scGFPs above that
seen for other cationic delivery agents such as the Tat
peptide. This charge-to-cell uptake relationship informs the
future identification or engineering of proteins for macro-
molecule delivery. The differences in endocytic transport
by low- and high-charge scGFPs and cationic peptides
suggest that intracellular trafficking processes also deter-
mine macromolecule delivery potency. Moreover, we have
identified an aspect of the interaction betweenmacromolec-
ular delivery agents and their target cells that, to our knowl-
edge, was previously undescribed. Using a detailed analysis
of the subcellular endosomal transport of scGFPs and
cationic peptides, we found that all of these agents exhibit
altered intracellular transport across a number of parame-
ters, and none is as efficiently transported to lysosomes as
would be expected for typical endosomal cargo targeted
for degradation. Given that lysosomal localization was anti-
correlated with functional delivery potency by these
proteins, it seems likely that alteration of trafficking is an
important postuptake factor indeterminingdeliverypotency,
perhaps in part by extending their lifetime in cells. In
summary this study reveals protein and cellular factors
that determine the effectiveness of cationic protein- and
peptide-based delivery agents, and implicates specific path-
ways that may explain their significant potency differences.
EXPERIMENTAL PROCEDURES
Complete experimental procedures are presented in the accompanying
Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Results, Supplemental
Experimental Procedures, and seventeen figures and can be found with this
article online at http://dx.doi.org/10.1016/j.chembiol.2012.06.014.
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